Union Budget 2026: Rs 10,000-cr 'Biopharma Shakti' to Boost Biologics Manufacturing

• Finance Minister Nirmala Sitharaman announced 'Biopharma Shakti' in Union Budget 2026.
• The program is a ₹10,000-crore strategy to strengthen India’s biologics ecosystem.
• It aims to position India as a global biopharmaceutical manufacturing hub.
• The five-year initiative focuses on building domestic capabilities in biologics and biosimilars.
• This is crucial as India's disease burden shifts towards non-communicable illnesses like diabetes, cancer, and autoimmune disorders.

Why It Matters: Union Budget 2026 introduces 'Biopharma Shakti' with ₹10,000-cr to boost India's biologics manufacturing.